Search
for
Sort by
Research 691–720 of 1000+
- Sessualità e sindrome dell’ovaio policistico
- Controversies in Polycystic Ovary Syndrome
- Sirtuins pathways and redox homeostasis: a pilot study on young and old monozygotic twins
- P.3.a.011 Dietary intake in subjects with early psychosis: is there a relationship with clinical subtype or antipsychotic treatment?
- Dermatological Issues in a Child with Diabetes Mellitus
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Retinoids in Dermatology
- Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
- Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone
- Increased Expression of TSPEAR in Colorectal Cancer Predicts Poor Prognosis
- Increased Expression of TSPEAR in Colorectal Cancer Predicts Poor Prognosis
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Syndrome des ovaires polykystiques : Point de vue contemporain
- Comprehensive clinical management of polycystic ovary syndrome.
- Structural abnormalities of the hair shaft
- Contraceptive use in acne
- Dermatological drugs, topical agents, and cosmetics
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Anti-anginal and beta-adrenoceptor blocking drugs
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Dermatological drugs and topical agents
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Evidence From Men for Ovary-independent Effects of Genetic Risk Factors for Polycystic Ovary Syndrome
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*